Skip to main content

Table 2 Review objective and PICO elements

From: A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer (NSCLC)

Review objective

The objective of this article is to review the economic evidence of treatment of NSCLC with targeted agents.

Participants

Studies of participants diagnosed with NSCLC. Studies were not restricted based on age of the participants or treatment lines.

Interventions/Comparison

Studies about treatments with approved targeted agents or agents still going through the approval process. The review is not limited to specific comparators

Outcomes

ICER, e.g. cost per QALY or cost per life year gained/saved

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us